CompletedNot Applicable

Radiologic Evaluation and Breast Density (READ)

United States1,704 participantsStarted 2004-11

Plain-language summary

The purpose of this study is to determine whether cessation of hormone replacement therapy for one or two months before a screening mammogram will improve its performance by decreasing breast density.

Who can participate

Age range45 Years – 80 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 1 or more prior screening mammograms at Group Health Cooperative within the past 2 years * Currently taking HRT * Taking HRT at prior screening mammogram * Due for a screening mammogram Exclusion Criteria: * BI-RADS breast density of 1 (entirely fat) * Previous cardiovascular events (heart surgery, catheterization, stent bypass, angioplasty, stroke, DVT) * Previous breast cancer * History of breast implants * Breast reduction since last mammogram * Mastectomy * History of using Tamoxifen or Raloxifene * Declined contact or use of data for research

What they're measuring

Mammogram Recall for Additional Imaging

Timeframe: 4 years

Mammographic Breast Density

Timeframe: 4 years

Trial details

NCT IDNCT00117663

SponsorKaiser Permanente

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2007-11

Results submitted2016-02-03

View on ClinicalTrials.gov More Breast Cancer trials